Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020. Herculean efforts to rapidly design and produce vaccines and other antiviral intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturley, Stephen L., Rajakumar, Tamayanthi, Hammond, Natalie, Higaki, Katsumi, Márka, Zsuzsa, Márka, Szabolcs, Munkacsi, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328045/
https://www.ncbi.nlm.nih.gov/pubmed/32457038
http://dx.doi.org/10.1194/jlr.R120000851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328045/
https://www.ncbi.nlm.nih.gov/pubmed/32457038
http://dx.doi.org/10.1194/jlr.R120000851

Ejemplares similares